Healthcare-Associated Infection in Developing Countries: Simple Solutions to Meet Complex Challenges by Allegranzi, Benedetta & Pittet, Didier
I N F E C T I O N CONTROL AND HOSPITAL EPIDEMIOLOGY DECEMBER 2 0 0 7 , VOL. 2 8 , NO. 12 
P O V E R T Y A N D H U M A N D E V E L O P M E N T : C O M M E N T A R Y 
Healthcare-Associated Infection in Developing Countries: 
Simple Solutions to Meet Complex Challenges 
Benedetta Allegranzi, MD; Didier Pittet, MD, MS 
Healthcare-associated infections are usually linked to so-
phisticated medical technology and the use of invasive de-
vices. Their potential impact on patient safety in developing 
countries is, therefore, perceived as incidental. Furthermore, 
in countries with an annual per capita income less than 
US$2,000 and where less than 5% of the gross national prod-
uct is spent for health, infection control may be considered 
a luxury that uses resources needed for other very pressing 
health priorities.1 Available data seem to clearly demonstrate 
that this point of view is distorted and subject to bias. 
In developing countries, the unsafe use of injection equip-
ment, other medical devices, and blood products; inadequate 
surgical procedures; and deficient biomedical waste manage-
ment result in thousands of infections acquired not only from 
patients, but also from healthcare workers—most of them 
unreported. The World Health Organization (WHO) esti-
mates that the proportion of injections given with syringes 
or needles that are reused without sterilization is between 
1.5% and 69.4% in transitional and developing countries.2 In 
a survey conducted in 22 developing countries, the percentage 
of facilities not using proper waste disposal methods ranged 
from 18% to 64%.2 Furthermore, in 2000-2001, the WHO 
announced the alarming fact that more than 70 countries did 
not test all donated blood for human immunodeficiency vi-
rus, hepatitis B, hepatitis C, and syphilis. As a consequence, 
unsafe blood transfusions and injections result in an astound-
ing number of new infections due to hepatitis B virus, hep-
atitis C virus, and human immunodeficiency virus every year 
(Table).2'3 
In industrialized countries, healthcare-associated infection 
is a complication for between 5% and 10% of patients ad-
mitted to acute care hospitals. In developing countries, the 
risk of infection is 2-20 times higher, and the proportion of 
patients infected can exceed 25%.4" In a recent study in in-
tensive care units (ICUs) in 8 developing countries, the overall 
device-associated infection rates were as high as 22.5 cases 
per 1,000 ICU-days, and the rates of specific device-associated 
infections exceeded by several times those reported in in-
dustrialized countries.9 Similarly, the rates of bloodstream 
infection in neonates are 3-20 times higher in developing 
countries, and, in some countries, approximately half of the 
patients in neonatal ICUs acquire an infection, and case fa-
tality rates may reach 52%.10 In developed countries, between 
2% and 5% of patients who undergo surgery develop a sur-
gical site infection; in developing countries, much higher rates 
are reported, ranging from 12% to 39%.211 
A complex range of factors determines the risk of acquiring 
an infection in healthcare settings in developing countries. 
The view that antimicrobial resistance substantially facilitates 
the spread of nosocomial pathogens is well known. In de-
veloping countries, inappropriate use of antibiotics and the 
use of counterfeit drugs contribute to very high resistance 
rates, although this is poorly documented because of the lack 
of reliable surveillance systems. In a report on neonatal ICU-
acquired infections in different countries, 36% of Staphylo-
coccus aureus isolates recovered were reported to be methi-
cillin-resistant strains (MRSA), and 46% of Escherichia coli 
strains and 51% of Klebsiella species strains were resistant to 
third-generation cephalosporins.10 In adult ICU patients, 
MRSA accounted for 84% of healthcare-associated infections, 
and third-generation cephalosporin-resistant Enterobacteri-
aceae accounted for 51%.9 
Understaffing and low levels of staff preparedness and 
knowledge are key factors leading to poor infection control 
in developing countries. The WHO Health Report 2006 re-
vealed that worldwide, 57 countries (all developing) currently 
have critical staff shortages, equivalent to a global deficit of 
2.4 million physicians, nurses, and midwives.12 Given this 
situation, the education and recruitment of infection control 
professionals is very far from being a realistic solution. Gov-
ernments struggling with other well-known health priorities 
clearly are not primarily committed to developing infection 
control policies and standards. Several factors make the im-
plementation of minimum standards for infection control 
very difficult, including poor hygiene and sanitation; lack or 
shortage of basic equipment, such as gloves; inadequate struc-
From the World Alliance for Patient Safety, World Health Organization Headquarters (B.A.), and Infection Control Programme, University of Geneva 
Hospitals, Geneva, Switzerland (B.A., D.P.). 
Received June 11, 2007; accepted July 11, 2007; electronically published October 22, 2007. 
Infect Control Hosp Epidemiol 2007; 28:1323-1327 
© 2007 by The Society for Healthcare Epidemiology of America. All rights reserved. 0899-823X/2007/2812-0002$15.00.DOI: 10.1086/521656 
https:/www.cambridge.org/core/terms. https://doi.org/10.1086/521656
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 30 May 2017 at 19:55:48, subject to the Cambridge Core terms of use, available at
1324 INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY DECEMBER 2 0 0 7 , VOL. 2 8 , N O . 12 
TABLE Estimated Worldwide Number of Infections Caused Each 
Year by Unsafe Injection and Blood Transfusion Practices 
Type of infection 
Cases due to 
unsafe injection 
Cases due to 
unsafe transfusion 
Hepatitis B virus 
Hepatitis C virus 
HIV 
21,000,000 
2,000,000 
260,000 
16,000,000 
5,000,000 
160,000 
NOTE. Estimates adapted from the World Health Organization Global 
Patient Safety Challenge2 and a report in The Lancet.3 HIV, human immu-
nodeficiency virus. 
tures and overcrowding; and limited availability of surveil-
lance data. In addition to these specific factors, a population 
widely affected by malnutrition and endemic infection con-
tributes to the increased risk of healthcare-associated infec-
tion in developing countries. Despite this discouraging pic-
ture, simple and applicable prevention measures and tools do 
exist. Their effectiveness has mostly been demonstrated in 
settings with adequate resources but remarkable examples of 
the implementation of interventions to reduce healthcare-
associated infection are also available from studies conducted 
in developing countries.13'18 
A global response to the problem of healthcare-associated 
infection has been recently initiated by the WHO World Al-
liance for Patient Safety. Given the critical nature of this health 
problem, the project was launched as the First Global Patient 
Safety Challenge, "Clean Care is Safer Care."219 It aims at 
reducing healthcare-associated infection worldwide by 
strengthening integrated actions in the areas of blood safety, 
injection safety, and clinical procedure safety, as well as water, 
sanitation, and waste management safety. The cornerstone of 
the entire initiative focuses on the promotion of hand hygiene 
in health care. The objectives of "Clean Care is Safer Care" 
will be achieved through 3 key efforts: (1) efforts to increase 
global awareness of healthcare-associated infection as a major 
issue threatening the safety of patients and healthcare work-
ers, (2) efforts to catalyze countries' commitment to make 
progress in this field, and (3) efforts to identify and test sound 
recommendations and strategies to implement basic infection 
control interventions in healthcare settings worldwide. 
During the first 18 months of the First Global Patient Safety 
Challenge, ministries of health from 43 countries signed a 
formal statement pledging to reduce healthcare-associated in-
fection; 22 of these 43 are developing countries. At least 20 
additional countries have planned to pledge by the end of 
2007; combined, this would represent 75% of the world's 
population. After making the pledge, several countries from 
the developing world, including Bahrain, Costa Rica, Iran, 
Malaysia, and Mali, have documented progress, such as the 
development of new infection control policies, the allocation 
of funds and human resources to infection control, the in-
auguration of training programs and surveillance systems, 
preparation of national guidelines, and actual implementation 
of interventions in healthcare settings. 
From rural dispensaries in developing countries to the most 
technologically-advanced tertiary care centers in the devel-
oped world, the lack of compliance with hand hygiene in 
healthcare settings remains problematic, despite the fact that 
hand hygiene is a simple, highly effective measure for re-
ducing the rate of healthcare-associated infection and the 
spread of antimicrobial resistance.20,21 The technical work of 
the First Global Patient Safety Challenge has addressed this 
issue by focusing on the improvement of hand hygiene in 
healthcare settings worldwide. To provide healthcare workers, 
Five Key Elements of the WHO Hand 
Hygiene Improvement Strategy 
la. System change- alcohol-based 
hand rub at point of care 
1b. System change -
access to safe, continuous 
supply; soap and towels 
2. Training and education 
3. Observation and feedback 
4. Reminders in the hospital 
5. Hospital safety climate 
o Five Moments for Hand Hygiene in Health Care 
Five-step implementation schedul, 
ffMBWffllW 'IffllHffl^BHMBllfllH Follow-up evaluation 
FIGURE i. The World Health Organization (WHO) multimodal implementation strategy to improve hand hygiene in healthcare settings. 
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FIGURE 2. Countries testing the World Health Organization multimodal implementation strategy to improve hand hygiene as of September 
2007. Rectangles, pilot sites; circles, complementary sites; flags, countries where a national or regional hand hygiene campaign is ongoing. 
hospital managers, and health authorities with the best evi-
dence and recommendations to improve practices, the WHO 
has put together the best scientific evidence available and 
drawn on expertise from more than 100 renowned interna-
tional experts and experienced clinical professionals to de-
velop the new "Guidelines on Hand Hygiene in Health Care 
(Advanced Draft)."22 This worldwide movement, catalyzed by 
the First Global Patient Safety Challenge, includes some 15 
countries that have already launched national or regional 
hand hygiene promotion campaigns, all of which refer to the 
WHO guidelines. 
A multimodal implementation strategy (Figure 1) has been 
developed to turn the scientific evidence included in the 
WHO guidelines into practice and to suggest feasible ways 
to induce changes that will ultimately result in increased hand 
hygiene compliance and reduced morbidity and mortality due 
to healthcare-associated infection. To enable any healthcare 
setting to easily start a hand hygiene improvement campaign, 
the proposed strategy includes 5 key elements based on sci-
entific evidence that are considered to be essential minimum 
requirements for improving hand hygiene. The strategy is 
suitable for both developed and developing countries. De-
pending on local resources and culture, additional actions 
might be included, for example, patient involvement. 
An implementation pack of practical tools is available to 
healthcare facilities to help with step-by-step implementation 
of all 5 key elements of the strategy. The tools address the 
following target areas: operation, advocacy and information; 
education; monitoring; hand hygiene product procurement; 
and impact evaluation. To make a real change, the indications 
for hand hygiene should be universally understandable and 
no longer open to interpretation. An innovative approach is 
proposed, therefore, which focuses on only 5 points in time 
when hand hygiene is required23 while providing health care 
and which aims at integrating the indications easily into the 
work flow (Figure 1). 
One of the key evidence-based changes that promote suc-
cessful hand hygiene is the systematic switch to alcohol-based 
hand rub at the point of care as the "gold standard" 
practice.24,25 To increase hand hygiene compliance worldwide, 
the WHO recommends making the use of alcohol-based hand 
rubs preferable to hand washing in most situations.22 Un-
fortunately, products already on the market are of varying 
quality and efficacy and are far too costly for healthcare set-
tings that have limited resources. To overcome this obstacle, 
2 hand rub formulations with proven microbiological efficacy 
and a good safety profile were identified by international 
experts that can be produced easily at the facility level. A 
"Guide to Local Production" is now available, which features 
simple instructions and illustrations detailing the process 
from procurement of raw ingredients to quality control and 
storage of the final product. Product tolerability and accept-
ability have been tested and are remarkable.22,26 
A worldwide pilot test of the strategy and tools is currently 
ongoing in a large number of healthcare settings in developed 
and developing countries (Figure 2). As shown, though less 
than 2 years have passed since the launch of the First Global 
Patient Safety Challenge, interventions to promote hand hy-
giene at the national or regional level are currently ongoing 
in at least 15 countries; there are also ongoing interventions 
at the level of the healthcare setting in an additional 18 coun-
tries. Several facilities from developing countries are partic-
ipating, and some (Costa Rica, Egypt, Kenya, Mali, and Mon-
golia) have already successfully implemented local production 
of the WHO-recommended alcohol-based formulations. As 
an example, the entire process of producing the WHO-rec-
ommended ethanol-based formulation, from the procure-
ment of raw ingredients to distribution, has been shown to 
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be feasible in a remote, rural hospital in Kenya at a cost of 
US$0.37 per 100 mL. When testing an intervention in dif-
ferent settings worldwide, it is also very important to take 
into account behavioral, transcultural, and religious factors 
that may influence the outcome. For this reason, the WHO 
Guidelines include a chapter that considers new aspects of 
hand hygiene promotion, including transcultural issues. For 
instance, some healthcare workers' possible reluctance to use 
alcohol-based hand rubs because alcohol is prohibited by 
some religions, particularly by Islam, is considered together 
with potential ways to overcome this obstacle.27 
The aim of the pilot test phase is to evaluate feasibility, 
sustainability, cost-effectiveness, and cultural adaptation of 
the proposed multimodal strategy for hand hygiene improve-
ment in settings with varying levels of development and to 
learn about the cultural needs that must be met for successful 
adaptation. Once the findings from the test phase have been 
collected and analyzed, the WHO Guidelines and the imple-
mentation strategy will be finalized. This approach has been 
judged to be an exemplar for WHO guideline preparation 
and, in particular, the implementation strategy may be used 
as a model for future interventions. Facilities that are inter-
ested in using the WHO multimodal strategy for hand hygiene 
improvement can register as complementary sites and access 
the tools freely via the Internet28; facilities that use the strategy 
are subsequently asked to share their experience and findings. 
Healthcare-associated infection has all the peculiar char-
acteristics of being a major patient safety problem from which 
no hospital, no healthcare system, and no country in the 
world can claim to be exempt. In developing countries, until 
recently the issues related to healthcare-associated infection 
were only considered in relation to epidemic events—that is, 
as part of a threatening health concern that required urgent 
attention. If insufficient infection control practices are in 
place, endemic transmission of harmful pathogens to patients 
and staff members ensues during the delivery of health care. 
Therefore, the lack of knowledge and the way that the prob-
lem is perceived are the basic determinants of the rate of 
healthcare-associated infection in developing countries, to-
gether with the adequacy of structures and equipment. 
The First Global Patient Safety Challenge represents an 
unprecedented initiative to improve infection control prac-
tices and procedures in any healthcare setting, regardless of 
the level of economic development. Never before in the his-
tory of infection control has there been such an opportunity 
to improve the health of so many millions of individuals by 
promoting basic but essential practices through the powerful 
channels of the WHO, which allow the involvement of gov-
ernments and influence their healthcare systems. The large 
number of countries that have already pledged to address 
healthcare-associated infection in only 18 months testifies to 
the desire for change on each continent. Results obtained 
from worldwide testing will be invaluable in helping to shape 
scale-up and sustainability worldwide and will go a long way 
toward ensuring that infection control practices continuously 
improve and contribute to enhanced patient safety. 
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